AbbVie Inc (ABBV)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

1 NORTH WAUKEGAN ROAD NORTH CHICAGO, IL 60064

AbbVie Inc. (AbbVie) is a research-based pharmaceuticals company. AbbVie products are used to treat rheumatoid arthritis, psoriasis, Crohn's disease, human immunodeficiency virus (HIV), cystic fibrosis complications, low testosterone, thyroid disease, Parkinson's disease and complications associated with chronic kidney disease, among other indications. AbbVie is a wholly owned subsidiary of Abbott Laboratories (Abbott). AbbVie's portfolio of products includes a line of adult and pediatric pharmaceuticals, which includes HUMIRA, metabolics/hormones products, virology products, endocrinology products, dyslipidemia products and other products. In October 2012, AbbVie initiated a comprehensive Phase III program for hepatitis C virus (HCV) genotype one.

Data as of 2020-06-06
Market Cap165.396 Billion Shares Outstanding1.762 Billion Avg 30-day Volume12.191 Million
P/E Ratio16.5 Dividend Yield5.029 EPS5.64
Price/Sales4.856 Price cash flow ratio9.8 Price free cash flow ratio26.5
Book Value-4.21 Price to Tangible Book-3.98 Alpha0.01
Short Interest Ratio2.0 % Short Interest to Float1.4 R-squared0.199726
BETA0.840955 52-week High/Low97.86 / 62.55 Stddev0.080778
View SEC Filings from ABBV instead.

View recent insider trading info

 
AbbVie Inc Chart by YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Check out our reporting and analysis

Funds Holding ABBV (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ABBV BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

42.5 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LEONARD JOHN M. PRESIDENT AND CEO

  • Officer
  • Director
 525,767 2020-06-03 0

AUSTIN ROXANNE S

  • Director
 34,838 2020-06-02 4

ROBERTS REBECCA B

4,717 2020-05-29 1

HART BRETT J PRESIDENT

  • Officer
 0 2020-05-21 1

FREYMAN THOMAS C

  • Director
 28,166 2020-05-20 5

GOSEBRUCH HENRY O

  • Director
 0 2020-05-20 5

MEYER MELODY B

  • Director
 25,110 2020-05-20 1

STEWART JEFFREY RYAN SVP, US COMMERCIAL OPERATIONS

  • Officer
 54,098 2020-05-12 5

WADDELL FREDERICK H

  • Director
 21,881 2020-05-08 1

TILTON GLENN F

  • Director
 44,837 2020-05-08 1

RAPP EDWARD J

  • Director
 35,870 2020-05-08 7

LIDDY EDWARD M

  • Director
 25,002 2020-05-08 5

BURNSIDE WILLIAM H.L.

  • Director
 19,881 2020-05-08 1

ALPERN ROBERT J

  • Director
 28,440 2020-05-08 5

DURKIN BRIAN L VP, CONTROLLER

  • Officer
 17,704 2020-05-08 7

STROM CARRIE C SVP & PRES GLOBAL ALLERG AESTH

  • Officer
 0 2020-05-08 2

RICHMOND TIMOTHY J. EVP, CHIEF HR OFFICER

  • Officer
 0 2020-05-05 4

SALEKI-GERHARDT AZITA

  • Director
 14,123 2020-04-29 2

GONZALEZ RICHARD A CHAIRMAN OF THE BOARD AND CEO

  • Officer
  • Director
 385,507 2020-04-28 8

SEVERINO MICHAEL

  • Director
 10,022 2020-04-23 2

SCHUMACHER LAURA J VICE CHAIRMAN

  • Officer
 206,491 2020-04-02 5

ALBAN CARLOS VICE CHAIRMAN

  • Officer
 208,666 2020-02-28 2

MICHAEL ROBERT A. EVP, CHIEF FINANCIAL OFFICER

  • Officer
 20,270 2020-02-28 2

DONOGHOE NICHOLAS SVP, ENTERPRISE INNOVATION

  • Officer
 15,149 2020-02-28 4

HUDSON THOMAS J SVP, R&D AND CSO

  • Officer
 19,643 2020-02-28 3

CHASE WILLIAM J EVP, FINANCE & ADMINISTRATION

  • Officer
 170,053 2019-06-26 1

HURWICH THOMAS A. VP, CONTROLLER

  • Officer
 No longer subject to file 2017-02-28 0

ROBERTS ROY S

  • Director
 27,486 2015-05-08 0

LINDER GREG W VICE PRESIDENT

  • Officer
 No longer subject to file 2013-02-28 0

ABBOTT LABORATORIES

  • 10% Owner
 0 2012-12-12 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

STEWART JEFFREY RYAN - Officer SVP, US COMMERCIAL OPERATIONS

2020-05-12 S 23,024 $90.00 d 52,760 54,098.00 direct

STROM CARRIE C - Officer SVP & PRES GLOBAL ALLERG AESTH

2020-05-11 A 23,196 a 63,538 63,538.00 direct

FREYMAN THOMAS C - Director

2020-05-08 A 2,333 a 119,675 127,557.00 direct

FREYMAN THOMAS C - Director

2020-05-08 A 2,583 a 117,342 123,675.00 direct

STROM CARRIE C - Officer SVP & PRES GLOBAL ALLERG AESTH

2020-05-08 A 3,613 a 3,613 63,538.00 direct

STROM CARRIE C - Officer SVP & PRES GLOBAL ALLERG AESTH

2020-05-08 A 2,017 a 2,017 63,538.00 direct

STROM CARRIE C - Officer SVP & PRES GLOBAL ALLERG AESTH

2020-05-08 A 7,809 a 7,809 63,538.00 direct

DURKIN BRIAN L - Officer VP, CONTROLLER

2020-05-08 A 60 a 17,704 17,704.00 direct

BURNSIDE WILLIAM H.L. - Director

2020-05-08 A 2,333 a 19,881 19,881.00 direct

MEYER MELODY B - Director

2020-05-08 A 2,333 a 9,421 9,421.00 direct

WADDELL FREDERICK H - Director

2020-05-08 A 2,333 a 21,881 21,881.00 direct

FREYMAN THOMAS C - Director

2020-05-08 A 2,583 a 117,342 127,557.00 direct

STROM CARRIE C - Officer SVP & PRES GLOBAL ALLERG AESTH

2020-05-08 A 3,440 a 3,440 63,538.00 direct

STROM CARRIE C - Officer SVP & PRES GLOBAL ALLERG AESTH

2020-05-08 A 5,729 a 5,729 63,538.00 direct

STROM CARRIE C - Officer SVP & PRES GLOBAL ALLERG AESTH

2020-05-08 A 4,184 a 4,184 63,538.00 direct

STROM CARRIE C - Officer SVP & PRES GLOBAL ALLERG AESTH

2020-05-08 A 37,903 a 40,342 63,538.00 direct

ALPERN ROBERT J - Director

2020-05-08 A 2,333 a 28,440 28,440.00 direct

HART BRETT J - Director

2020-05-08 A 2,333 a 12,395 12,395.00 direct

ROBERTS REBECCA B - Director

2020-05-08 A 2,333 a 6,651 6,651.00 direct

RAPP EDWARD J - Director

2020-05-08 A 2,333 a 32,995 35,870.00 direct

FREYMAN THOMAS C - Director

2020-05-08 A 2,333 a 119,675 123,675.00 direct

STROM CARRIE C - Officer SVP & PRES GLOBAL ALLERG AESTH

2020-05-08 A 2,567 a 2,567 63,538.00 direct

STROM CARRIE C - Officer SVP & PRES GLOBAL ALLERG AESTH

2020-05-08 A 6,370 a 6,370 63,538.00 direct

STROM CARRIE C - Officer SVP & PRES GLOBAL ALLERG AESTH

2020-05-08 A 4,184 a 4,184 63,538.00 direct

STROM CARRIE C - Officer SVP & PRES GLOBAL ALLERG AESTH

2020-05-08 A 2,439 a 2,439 63,538.00 direct

AUSTIN ROXANNE S - Director

2020-05-08 A 2,333 a 119,447 119,447.00 direct

LIDDY EDWARD M - Director

2020-05-08 A 2,333 a 25,002 25,002.00 direct

TILTON GLENN F - Director

2020-05-08 A 2,333 a 44,487 44,837.00 direct

RICHMOND TIMOTHY J. - Officer EVP, CHIEF HR OFFICER

2020-05-05 S 19,445 $85.00 d 0 0.00 direct

GONZALEZ RICHARD A - Director - Officer CHAIRMAN OF THE BOARD AND CEO by step-daughter

2020-04-28 G 5,450 a 5,900 385,507.00 indirect

GONZALEZ RICHARD A - Director - Officer CHAIRMAN OF THE BOARD AND CEO by spouse

2020-04-28 G 10,900 a 17,615 385,507.00 indirect

GONZALEZ RICHARD A - Director - Officer CHAIRMAN OF THE BOARD AND CEO by step-son

2020-04-28 G 5,450 a 5,900 385,507.00 indirect

GONZALEZ RICHARD A - Director - Officer CHAIRMAN OF THE BOARD AND CEO

2020-04-28 G 21,800 d 356,092 385,507.00 direct

Elevate your investments